e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Longitudinal and cross sectional risk factors for COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic bronchitis and plasma markers of inflammation predict incidence of COPD
G. Engström, M. Ekberg-Aronsson, P. Nilsson, F. Lindgärde, C. G. Löfdahl (Malmö, Sweden)
Source:
Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Session:
Longitudinal and cross sectional risk factors for COPD
Session type:
Oral Presentation
Number:
4017
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Engström, M. Ekberg-Aronsson, P. Nilsson, F. Lindgärde, C. G. Löfdahl (Malmö, Sweden). Chronic bronchitis and plasma markers of inflammation predict incidence of COPD. Eur Respir J 2007; 30: Suppl. 51, 4017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Inflammatory changes, recovery and recurrence at COPD exacerbation
Source: Eur Respir J 2007; 29: 527-534
Year: 2007
Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009
Defining the contribution of emphysema and chronic bronchitis in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 539s
Year: 2003
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept